Protective and toxic antibodies in prion diseases
Karl Frontzek(University Hospital of Zurich)
Cited by 1
Related Papers
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
|Science Advances|2021|33
A conformational switch controlling the toxicity of the prion protein
|Nature Structural & Molecular Biology|2022|32